Bryan Wahl
General Counsel · 3 filings · Latest: Mar 17, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Bryan Wahl | General Counsel | Mar 19, 2026 | Sale | $67.00 | 4,231 | $283.5K | 63,959 | |
TARS | Bryan Wahl | General Counsel | Mar 18, 2026 | Sale | $68.71 | 4,125 | $283.4K | 68,190 | |
TARS | Bryan Wahl | General Counsel | Mar 17, 2026 | Sale | $69.42 | 4,084 | $283.5K | 72,315 | |
TARS | Wahl Bryan | — | Mar 19, 2026 | Proposed Sale | $67.00 | 4,231 | $283.5K | — | |
TARS | Wahl Bryan | — | Mar 18, 2026 | Proposed Sale | $68.71 | 4,125 | $283.4K | — | |
TARS | Bryan Wahl | General Counsel | Mar 15, 2026 | Option Exercise | — | 24,236 | — | 76,399 | |
TARS | Wahl Bryan | — | Mar 17, 2026 | Proposed Sale | $69.41 | 4,084 | $283.5K | — | |
TARS | Wahl Bryan | — | Mar 20, 2025 | Proposed Sale | $50.11 | 3,084 | $154.6K | — | |
TARS | Wahl Bryan | — | Mar 19, 2025 | Proposed Sale | $47.40 | 3,261 | $154.6K | — | |
TARS | Wahl Bryan | — | Mar 18, 2025 | Proposed Sale | $46.28 | 3,341 | $154.6K | — |